After anti-extradition bill movement, Hong Kong government strives to attract key enterprises, latest 22 settle in
After the "anti-extradition bill" movement and the COVID-19 pandemic, the Hong Kong government has been dedicated to attracting key enterprises. It announced the latest batch of 22 overseas or mainland Chinese companies setting up or expanding their operations in Hong Kong, expected to bring HK$73 billion in investment and 25,000 jobs.
📋 Article Processing Timeline
- 📰 Published: April 21, 2026 at 11:21
- 🔍 Collected: April 21, 2026 at 11:31 (10 min after Published)
- 🤖 AI Analyzed: April 21, 2026 at 11:51 (19 min after Collected)
Central News Agency
(Central News Agency reporter Zhang Qian, Hong Kong 21st) The Hong Kong authorities have newly attracted 22 overseas or mainland Chinese key enterprises to settle in Hong Kong for the first time or expand their operations in Hong Kong. This is one of the achievements of the authorities' efforts to attract key enterprises after the "anti-extradition bill" movement and the COVID-19 pandemic.
The Hong Kong Office for Attracting Strategic Enterprises (OASES) held a signing ceremony with 22 companies yesterday, presided over by Financial Secretary Paul Chan Mo-po.
According to the announcement, among the 22 key enterprises, most have a market value exceeding HK$100 billion (approximately NT$400 billion). These "hundred-billion giants" include the top 10 and top 20 pharmaceutical companies globally, all leaders in the field of life and health technology.
They also include other industry giants in fields such as advanced microprocessor manufacturing, general artificial intelligence, smart mobility technology, global innovative electric vertical take-off and landing (eVTOL) aircraft, low-altitude economy infrastructure, digital asset custody and wallet infrastructure, and international game development.
Since the end of 2023, OASES has attracted over 120 key enterprises to settle in Hong Kong or expand their operations in Hong Kong. The Hong Kong government expects these enterprises to bring HK$73 billion in investment and create approximately 25,000 jobs in the coming years, covering high-end R&D and management positions, injecting impetus into Hong Kong's industrial upgrading and talent development.
In 2019, the "anti-extradition bill" movement erupted in Hong Kong, which was the largest political demonstration in Hong Kong's history, plunging the city into instability. In early 2020, followed by the COVID-19 pandemic hitting Hong Kong, the city's economy and people's livelihoods were severely impacted.
To address this, the Hong Kong government established OASES at the end of 2022, directly led by the Financial Secretary, hoping to proactively attract representative and high-potential key enterprises from all over the world to enhance Hong Kong's competitiveness and accelerate industrial development.
OASES primarily targets enterprises in life and health technology, artificial intelligence and data science, FinTech, advanced manufacturing, new materials, and new energy technology.
To attract relevant enterprises to develop in Hong Kong, the Hong Kong government will provide one-stop supporting services in terms of land, finance, and taxation.
The aforementioned 22 enterprises are the 6th batch of attracted enterprises, including Boehringer Ingelheim (Hong Kong) Limited (Germany), Pfizer R&D Co., Ltd. (USA), China Tower Corporation Limited, Dassault Systèmes, Didi, and Jiangsu Hengrui Medicine Co., Ltd. (Editor: Zhu Jianling) 1150421
Choose to stand with facts, every sponsorship you make is the power to protect press freedom.
Download the Central News Agency "First-hand News" APP to stay updated with the latest news.
The text, images, and audio-visual content of this website may not be reproduced, publicly broadcast, publicly transmitted, or utilized without authorization.
(Central News Agency reporter Zhang Qian, Hong Kong 21st) The Hong Kong authorities have newly attracted 22 overseas or mainland Chinese key enterprises to settle in Hong Kong for the first time or expand their operations in Hong Kong. This is one of the achievements of the authorities' efforts to attract key enterprises after the "anti-extradition bill" movement and the COVID-19 pandemic.
The Hong Kong Office for Attracting Strategic Enterprises (OASES) held a signing ceremony with 22 companies yesterday, presided over by Financial Secretary Paul Chan Mo-po.
According to the announcement, among the 22 key enterprises, most have a market value exceeding HK$100 billion (approximately NT$400 billion). These "hundred-billion giants" include the top 10 and top 20 pharmaceutical companies globally, all leaders in the field of life and health technology.
They also include other industry giants in fields such as advanced microprocessor manufacturing, general artificial intelligence, smart mobility technology, global innovative electric vertical take-off and landing (eVTOL) aircraft, low-altitude economy infrastructure, digital asset custody and wallet infrastructure, and international game development.
Since the end of 2023, OASES has attracted over 120 key enterprises to settle in Hong Kong or expand their operations in Hong Kong. The Hong Kong government expects these enterprises to bring HK$73 billion in investment and create approximately 25,000 jobs in the coming years, covering high-end R&D and management positions, injecting impetus into Hong Kong's industrial upgrading and talent development.
In 2019, the "anti-extradition bill" movement erupted in Hong Kong, which was the largest political demonstration in Hong Kong's history, plunging the city into instability. In early 2020, followed by the COVID-19 pandemic hitting Hong Kong, the city's economy and people's livelihoods were severely impacted.
To address this, the Hong Kong government established OASES at the end of 2022, directly led by the Financial Secretary, hoping to proactively attract representative and high-potential key enterprises from all over the world to enhance Hong Kong's competitiveness and accelerate industrial development.
OASES primarily targets enterprises in life and health technology, artificial intelligence and data science, FinTech, advanced manufacturing, new materials, and new energy technology.
To attract relevant enterprises to develop in Hong Kong, the Hong Kong government will provide one-stop supporting services in terms of land, finance, and taxation.
The aforementioned 22 enterprises are the 6th batch of attracted enterprises, including Boehringer Ingelheim (Hong Kong) Limited (Germany), Pfizer R&D Co., Ltd. (USA), China Tower Corporation Limited, Dassault Systèmes, Didi, and Jiangsu Hengrui Medicine Co., Ltd. (Editor: Zhu Jianling) 1150421
Choose to stand with facts, every sponsorship you make is the power to protect press freedom.
Download the Central News Agency "First-hand News" APP to stay updated with the latest news.
The text, images, and audio-visual content of this website may not be reproduced, publicly broadcast, publicly transmitted, or utilized without authorization.